MedPath
NMPA Approval

Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation

国药准字HJ20180005

January 4, 2023

H20180005

Drug Information

乌美溴铵维兰特罗吸入粉雾剂

欧乐欣

吸入粉雾剂

每泡含乌美溴铵62.5μg(按C₂₉H₃₄NO₂计)与三苯乙酸维兰特罗25μg(按C₂₄H₃₃Cl₂NO₅计),递送剂量为乌美溴铵55µg(按C₂₉H₃₄NO₂计)与三苯乙酸维兰特罗22µg(按C₂₄H₃₃Cl₂NO₅计)。

化学药品

January 4, 2023

January 3, 2028

Company Information

Applicant Company

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Manufacturing Company

Priory Street, Ware, Hertfordshire SG12 0DJ, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

乌美溴铵维兰特罗吸入粉雾剂 - NMPA 批准文号 | MedPath